Emerald Mutual Fund Advisers Trust’s Amicus Therapeutics FOLD Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-494,917	Closed	-$7.73M	–	249
2018 Q2	$7.73M	Buy	+494,917	New	+$7.48M	0.28%	132
2016 Q4	–	Sell	-1,270,437	Closed	-$9.4M	–	293
2016 Q3	$9.4M	Buy	1,270,437 +165,610	+15%	+$1.12M	0.48%	83
2016 Q2	$6.03M	Sell	1,104,827 -948,398	-46%	-$6.63M	0.34%	107
2016 Q1	$17.4M	Buy	2,053,225 +87,647	+4%	+$621K	0.97%	31
2015 Q4	$19.1M	Buy	1,965,578 +931,494	+90%	+$8.39M	1.01%	26
2015 Q3	$14.5M	Buy	1,034,084 +240,422	+30%	+$3.77M	0.95%	29
2015 Q2	$11.2M	Buy	793,662 +212,100	+36%	+$2.55M	0.87%	39
2015 Q1	$6.2M	Buy	+581,562	New	+$5.13M	0.51%	75

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's FOLD Position: Q3 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Amicus Therapeutics (FOLD) in Q3 2018, closing a stake of 494,917 shares — an estimated $7.73M sold.

Emerald Mutual Fund Advisers Trust first reported a position in FOLD in Q1 2015 and held it in 8 quarters. The position peaked at $19.1M in Q4 2015. 204 funds tracked by Wall St. Rank hold FOLD as of Q3 2018.

Emerald Mutual Fund Advisers Trust reported no remaining Amicus Therapeutics position as of Q3 2018 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 494,917 Amicus Therapeutics shares in Q3 2018, an estimated $7.73M.
Emerald Mutual Fund Advisers Trust first reported a position in Amicus Therapeutics in Q1 2015 and held it in 8 quarters.
Emerald Mutual Fund Advisers Trust's Amicus Therapeutics position peaked at $19.1M in Q4 2015.
204 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2018, filed 31 Oct 2018.